Citations(1)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(1261)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2014 Month : July Volume : 3 Issue : 30 Page : 8333-8339

COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF ETORICOXIB VS PLACEBO AS PREENPTIVE ANALGESIA FOR ACUTE POSTOPERATIVE PAIN RELIEF IN ORTHOPEDIC SURGERIES

B. Sowbhagya Lakshmi1, P. Krishna Prasad2, M. Santhi Sree3, Nageswar Rao4

1. Professor and HOD, Department of Anaesthesiology and Critical Care, Rangaraya Medical College, Kakinada.
2. Associate Professor, Department of Anaesthesiology and Critical Care, Rangaraya Medical College, Kakinada.
3. Assistant Professor, Department of Anaesthesiology and Critical Care, Rangaraya Medical College, Kakinada.
4. Post Graduate, Department of Anaesthesiology and Critical Care, Rangaraya Medical College, Kakinada.

CORRESPONDING AUTHOR

Dr. B. Sowbhagya Lakshmi,
Email : drbslakshmi_80rmc@yahoo.co.in

ABSTRACT

CORRESPONDING AUTHOR:
Dr. B. Sowbhagya Lakshmi,
Professor and HOD,
Department of Anesthesiology,
Rangaraya Medical College,
G. G. H, Kakinada.
Email: drbslakshmi_80rmc@yahoo.co.in

ABSTRACT: BACKGROUND: Etoricoxib, a selective Cox-2 inhibitor has been found to be effective as preemptive analgesia for acute postoperative pain. This study evaluates the effect of preoperative use of oral etoricoxib on postoperative pain relief and sleep in patients undergoing lumbar laminectomies. MATERIALS & METHODS: In this prospective, randomized controlled study, fifty patients (ASA I & II) aged between 20-50yrs scheduled to undergo lumbar laminectomies were given either etoricoxib 120mg (Group E) or placebo (Group P) orally one hour before surgery. Visual analog score (VAS) was assessed at 0, 6, 12, 18, and 24 hours at rest and on movement. Sleep overnight, total fentanyl consumption, incidence of nausea and vomiting, intra-operative blood loss and patient satisfaction were noted. RESULTS: In our study we found that there was reduction in VAS at rest and on movement in the etoricoxib group when compared with the control group at all intervals till 24 hours postoperatively. Total fentanyl consumption was higher in control group in postoperative period. CONCLUSION: Single preoperative oral dose (120mg) of etoricoxib given one hour before surgery, has significantly reduced the postoperative pain at rest and on movement and improved sleep in patients undergoing lumbar laminectomies without any side effects and with good patient’s satisfaction.

KEYWORDS: Etoricoxib, selective Cox-2 inhibitors, preemptive analgesia, postoperative analgesia

INTRODUCTION: Multimodel analgesia using a combination of analgesics throughout perioperative period to control postoperative pain is an important part of anesthesia management and is well accepted.(1,2) Acute postoperative pain is usually treated with opioids and Non-steroidal anti-inflammatory agents (NSAIDS). Opioids are associated with side effects like sedation, respiratory depression, nausea and vomiting, urinary retention, ileus and constipation.(3,4) The nonselective NSAIDS inhibit both forms of cyclooxygenase (COX) enzymes and are associated with increased risk of perioperative bleeding, renal dysfunction and gastrointestinal disturbances.(5,6)

Among the NSAIDS is new generation of Cox-2 inhibitors of which etoricoxib is a member. Cox-2 selective inhibitor is a form of NSAID that directly targets cyclooxygenase-2, an enzyme responsible for inflammation and pain and devoid of side effects of Cox-1 enzyme inhibition like less gastrointestinal toxicity and no effects on platelet aggregation.(7)

Etoricoxib has been effective in providing analgesia in ambulatory surgeries, dental procedures, laparoscopic cholecystectomy and knee repair.(8) It is safe and effective in treating postoperative pain with minimal side effects. Pain in patients with spine pathology is different from other types of pain, because these people have chronic pain and this may flare up in acute postoperative period. Sleep disturbances are common in postoperative period and it adds to discomfort of patients.(9)

PRE-EMPTIVE ANALGESIA: Transmission of pain signals evoked by tissue damage leads to sensitization of peripheral and central pain pathways. Pre-emptive analgesia is a treatment that is initiated before the surgical procedure in order to reduce this sensitization owing to this protective effect on nociceptive system. We hypothesized that a single preoperative dose of etoricoxib (Cox-2 inhibitor) is effective as preemptive analgesic in control of acute postoperative pain following laminectomy.

AIM OF THE STUDY: Our aim of the study is to evaluate the efficacy of single preoperative dose of Etoricoxib (120mg oral) vs placebo (B-complex) as a preemptive analgesic in control of acute post- operative pain in laminectomy surgeries.

MATERIALS & METHODS: This prospective randomized double blind, placebo controlled study was conducted in orthopedic OT and ward, Government general Hospital attached to Rangaraya Medical College, Kakinada between May 2013 to August 2013. After obtaining institutional ethical committee approval &informed consent from patients, 50 patients belonging to ASA grade I&II, of both sexes, aged between 20-50years were taken up for study.

They were randomly divided into 2 groups, Group E and Group P each comprising of 25 patients.

    

        Inclusion Criteria                                                                  Exclusion Criteria

Age between 20-50years                                                         Age < 20years, H/o of asthma

Patients posted for laminectomy                                               Gastritis, coagulation disorders

ASA grade I&II                                                                            Hepatic & renal dysfunction

Uncontrolled HTN

Lactating women

Hypersensitivity to NSAIDS

 

Group E: Patients received Tab. Etoricoxib 120mg orally 60mins before surgery with sips of water.

Group P: Patients received Tab. B-complex orally 60mins before surgery with sips of water. All the patients in both the groups were pre medicated with tab. Lorazepam 1mg and tab. Rabiprazole 10mg in the night before surgery.

Study drug and placebo were identical and were given in a folded cover to the patients by the assistant as it was a double blinded study. Base line parameters like pulse rate, NIBP, respiratory rate and SpO2 were recorded in both the groups. Both Groups were given standard general anesthesia with inj. Glycopyrrolate 10µg/kg IV, inj. Ondansetron 0.1mg/kg IV., inj. Fentanyl 1µg/kg IV as premedication and induced with inj.

Thiopentone sodium 5mg/kg IV, intubated after giving vecuronium 0.1mg/kg IV with appropriate sized endotracheal tube. Anaesthesia was maintained with increments of vecuronium, oxygen & nitrous oxide mixture 40%: 60% and isoflurane 1-1.5%. Intra operatively, inj. Fentanyl 1µg/kg increments were given when there was considerable rise in heart rate and NIBP. After surgery, patients were reversed with inj. Glycopyrrolate 10µg/kg IV and Neostigmine 50-70µg/kg IV, extubated and shifted to recovery room after complete recovery from neuromuscular blockade, monitored for 24 hours in the PACU. In all the patients continuous monitoring of heart rate, NIBP, Spo2 was done throughout the surgery and for 24 hours in the PACU.

In both the groups we observed& compared severity of post-operative pain at rest and on movement, sleep at night, total fentanyl consumption, total drain output at the end of 24 hours, incidence of side effects like nausea and vomiting, satisfaction from pain in terms of facial expression and body language

Statistical Analysis: Data analysis was performed by unpaired student’s t-test and chi-square test. SPSS 14.0 was used for statistical analysis. P < 0.05 was considered statistically significant and a p value < 0.0001 was considered statistically very significant.

RESULTS: The demographic profiles of the patients in both the groups were comparable with regards to age, sex, height, weight and duration of surgeries (Tab-I). Pain score was assessed using visual analogue scale (0-100mm) at time points 0, 6, 12, 18, 24 hours when patient was at rest (static) and on movement (dynamic), (Fig-I).

Patients in group E had lower VAS score compared to group P at 0, 6, 12, 18, 24 hours both at rest and during movement and it is statistically significant (p<0.05) (Bar-dia-I, II). Patients were given rescue analgesic dose when VAS pain score was>40. (Inj. Fentanyl 1µg/kg IV).Less opioid consumption (µg/kg/hr) in group E compared to group P and is statistically significant (p=0.007) (Tab-II). Sleep, facial expression, body language were assessed after 24hours following surgery, i.e.

 Pain satisfaction scale (Tab-III) Sleep at night was assessed subjectively as 1=good, 2=interrupted, 3=no sleep. Facial expression was assessed as 1=contended, 2=sad, 3=frightened. Body language was assessed as 1=relaxed, 2=tensed, 3=unhappy.

DISCUSSION: Our results demonstrated that preoperative use of oral etoricoxib, 120mg one hour before surgery reduced the postoperative analgesic requirement after lumbar laminectomy. Sleep at night, facial expression and body language were better with the use of etoricoxib whereas there was no increase in intra-operative blood loss and side effects.

Pre-emptive analgesia is a new strategy of postoperative pain management. The key concept is to prevent the altered sensory processing from surgical process. There are a number of medications being tested for pre-emptive analgesia, including opioids, anesthetic drugs and NSAIDS with conflicting results.(10-12,4,13,14) Our results found that etoricoxib was efficacious for use as pre-emptive analgesia after major orthopedic surgeries.

Etoricoxib is a second generation Cox-2 inhibitor with 100 fold increases in selectivity for Cox-2 over Cox-1. This reduces prostaglandin (PGS) generation from arachidonic acid. It has been found to be safe and effective in management of acute pain in different surgical conditions.(15-17)

NSAIDS (Nonselective Cox) have analgesic effect and opiate sparing effect and proven to be effective in major surgeries, but gastrointestinal bleeding and bleeding from operative site are the major concerns. So selective Cox-2 inhibitors are used as pre-emptive analgesics.

Etoricoxib with its convenient single daily dosing and long half-life (24.8hrs) was found to be superior in relief of postoperative pain.

Etoricoxib due to its short onset and long duration of action was also proved to be useful as a pre-emptive analgesic, in ambulatory gynecological surgeries.(8) Preoperative use of etoricoxib 120mg was found to be equally effective with etoricoxib and paracetamol combination for postoperative pain relief after laparoscopic cholecystectomy, when pain intensity and opioid sparing effects were compared.(4) Kitti J- et al showed that parecoxib reduces postoperative pain in spinal surgery patients and this study is comparable with our study.(18)

Studies have shown that adequate postoperative pain control is an important determinant of patient satisfaction.(19, 20) Better satisfaction expressed as contended facial expression and relaxed body language was due to superior postoperative pain relief in patients of etoricoxib group in our study. Postoperative sleep disturbance may contribute to the development of episodic hypoxemia, haemodynamic instability and altered mental states, all of which have an influence on postoperative morbidity and mortality.

In our study we found that group which received etoricoxib had better quality of sleep. This is due to decreased pain, reduced stress response and less need for opioids which inhibit random eye movement (REM) sleep and slow wave sleep (SWS).(21) Common side effects of Cox-2 inhibitors and other NSAIDS are fluid retention, hypertension and renal damage, particularly in the elderly. None of such problems have been encountered in any of our cases.

CONCLUSION: Based on this study we conclude that preoperative oral etoricoxibis an effective preemptive analgesic as it resulted in significantly less post-operative pain scores both at rest and during movement and less consumption of opioid postoperatively and a better satisfaction from pain with less incidence of side effects.

 

REFERENCES:

1.    Sinatra R: Role of Cox-2 inhibitors in the evolution of acute pain management. J pain symptom managment 2002, 24 (1suppl): S18-27.
2.    White PF: The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg 2005, 101: 55-22.
3.    White PF: The role of non-opiod analgesic techniques in the management of pain after ambulatory surgery. AnesthAnalg 2002, 94: 577-85.
4.    Puura A, Puolakka P, Rorarius M, Salmelin R, Lindgren L: Etoricoxib pre-medication for post-operative pain after laparoscopic cholecystectomy. Acta Anaesthesiol Scand 2006, 50: 688-93.
5.    Rosenblum M, Weller RS, Conard PL, Falvey EA, Gross JB: Ibuprofen provides longer lasting analgesia than fentanyl after laparoscopic surgery. Anesth Analg; 1991, 73: 255-9.
6.    Buggy DJ, Wall C, Carton EG: Preoperative or postoperative diclofenac for laparoscopic tubal ligation. Br. J. Anaesth; 1994, 73: 767-70.
7.    Stitchtenoth DO, Frolich JC: The second generation of Cox-2 inhibitors: what advantages do the newest offer? Drugs 2003, 63: 33-45.
8.    LIU W, Loo CC, Chiu JW, Tan HM, Ren HZ, Lim Y: Analgesic efficacy of pre-operative etoticoxib for termination of pregnancy in an ambulatory centre. Singapore med J; 2005, 46: 397-400.
9.    Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J: Postoperative sleep disturbances: Mechanisms and clinical implications. British Journal of Anaesthesia; 1996, 76: 552-559.
10.    Michaloliakou C, Chung F, Sharma S: Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. AnesthAnalg1996, 82: 44-51.
11.    Llan Dl, Liporace FA, Rosen J, Cannavo D: Efficacy of rofecoxib for pain control after knee arthroscopy: a prospective, randomized, double-blinded clinical trial. Arthroscopy 2004, 20: 813-8.
12.    Ekman EF, Wahba M, Ancona F: Analgesic efficacy of preoperative celecoxib in ambulatory arthroscopic knee surgery: a double-blind, placebo control study. Arthroscopy 2006, 22: 635-42.
13.    Recart A, issioui T, White PF, Klein K, Watcha MF, Stool L, Shah M: The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: a dose-ranging study. AnesthAnalg 2003, 96: 1631-5.
14.    Issioui T, Klein K, White PF, Watcha MF, Coloma M, Skrivanek G, et al: The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngology surgery. Anesth Analg 2002, 94: 1188-93.
15.    Malmstrom K, Kotey P, Coughlin H, Desjardin PJ: A randomized, double blind, parallel-group study comparing the analgesic effects of etoricoxib to placebo, naproxen sodium, and acetaminophen with codeine using the dental impaction pain model. Clinical Journal of pain; 2004, 20: 147-55.
16.    Chang Dj, Desjarding PJ, King TR, ERB T, GEBA GP: The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: a randomized, double-blind clinical trial. AnesthAnalg; 2004, 99: 807-15.
17.    Malmstrom K, Sapre A, Couglin H, Agarwal NG, Mazenko RS, Fricke JR JR: Etoricoxib in acute pain associated with dental surgery: a randomized, double blind, placebo – and active comparator-controlled dose ranging study. ClinTher; 2004, 26: 667-79.
18.    Jirarattanaphochai K, Thienthong S, Sriraj W, Jungs, Pulnitiporn A, Lertsinudom S, Foocharoen T: Effect of parecoxib on postoperative pain after lumber spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial. Spine (Phila Pa 1976); 2008, 33 (2): 132-9.
19.    Jamison RN, Taft K, O’Hara JP, Ferrante FM: Psychosocial and pharmacologic predictors of satisfaction with intravenous patient-controlled analgesia. Anesth Analg; 1993, 77: 121-5.
20.    Ready LB: Postoperative pain management-beyond basics. Can J Anaesth; 196, 43: 193-4.
21.    Rosenberg J, Rosenberg-Adamsen S, Kehlet H: Post-operative sleep disturbance: causes, factors and effects on outcome. Eur J Anesthesiolsuppl; 1995, 10: 28-30.

 

GROUPS

GROUP E (n=25)

GROUP P (n=25)

AGE (YEARS)

39.9 10.3

39.6 11.1

SEX (M/F)

15/10

13/12

WEIGHT (Kg)

62.4 + 11.2

61.2 + 12.2

HEIGHT (cm)

165.8 + 6.3

167.6 + 7.1

DURATION OF ANAESTHESIA (min)

155 + 30.0

160 + 28.2

INTRA OPERATIVE BLOOD LOSS (ml)

186.20 + 48.6

190.6 + 53.5

TABLE - I SHOWING DEMOGRAPHIC VARIABLES

 

TIME

GROUPS

GROUP - E

GROUP - P

P VALUE

O HOURS

AT REST

20

55

0.001

 

MOVEMENT

30

55

0.003

6 HOURS

AT REST

22.5

45

0.008

 

MOVEMENT

27.5

50

0.003

12 HOURS

AT REST

20

40

0.001

 

MOVEMENT

27.5

45

0.006

18 HOURS

AT REST

20

35

0.06

 

MOVEMENT

30

40

0.02

24 Hours

AT REST

15

30

0.012

 

MOVEMENT

20

35

0.33

TOTAL FENTANYL

CONSUMTION (ug/kg/hr)

 

450.8

668

0.007

TABLE – II SHOWING TOTAL FENTANYL CONSUMPTION

 

 

GROUP

 

GROUP – E (n-25)

GROUP – P (n-25)

SLEEP

GOOD

15

7

(p – 0.00)

INTERRUPTED

8

14

 

NO SLEEP

2

4

FACIAL EXPRESSION

CONTENDED

15

6

(p – 0.003)

SAD

7

13

 

FRIGHTENED

3

6

BODY LANGUAGE

RELAXED

16

8

(p – 0.004)

TENSED

6

12

 

UN HAPPY

3

5

TABLE – III SHOWING SLEEP, FACIAL EXPRESSION, BODY LANGUAGE SCORING

 

BAR DIAGRAM I: SHOWING VAS SCORE AT REST


BAR DIAGRAM II: SHOWING VAS SCORE AT MOVEMENT


Figure1: Showing Visual Analogue Scale



Videos :

watch?v